Abstract:Resistance to insulin-stimulated glucose uptake is present in the majority of patients with impaired glucose tolerance (IGT) or non-insulin-dependent diabetes mellitus (NIDDM) and in ∼25% of nonobese individuals with normal oral glucose tolerance. In these conditions, deterioration of glucose tolerance can only be prevented if the β-cell is able to increase its insulin secretory response and maintain a state of chronic hyperinsulinemia. When this goal cannot be achieved, gross decompensation of glucose homeostasis occurs. The relationship between insulin resistance, plasma insulin level, and glucose intolerance is mediated to a significant degree by changes in ambient plasma free-fatty acid (FFA) concentration. Patients with NIDDM are also resistant to insulin suppression of plasma FFA concentration, but plasma FFA concentrations can be reduced by relatively small increments in insulin concentration.Consequently, elevations of circulating plasma FFA concentration can be prevented if large amounts of insulin can be secreted. If hyperinsulinemia cannot be maintained, plasma FFA concentration will not be suppressed normally, and the resulting increase in plasma FFA concentration will lead to increased hepatic glucose production. Because these events take place in individuals who are quite resistant to insulinstimulated glucose uptake, it is apparent that even small increases in hepatic glucose production are likely to lead to significant fasting hyperglycemia under these conditions. Although hyperinsulinemia may prevent frank decompensation of glucose homeostasis in insulin-resistant individuals, this compensatory response of the endocrine pancreas is not without its price. Patients with hypertension, treated or untreated, are insulin resistant, hyperglycemic, and hyperinsulinemic. In addition, a direct relationship between plasma insulin concentration and blood pressure has been noted. Hypertension can also be produced in normal rats when they are fed a fructose-enriched diet, an intervention that also leads to the development of insulin resistance and hyperinsulinemia. The development of hypertension in normal rats by an experimental manipulation known to induce insulin resistance and hyperinsulinemia provides further support for the view that the relationship between the three variables may be a causal one. However, even if insulin resistance and hyperinsulinemia are not involved in the etiology of hypertension, it is likely that the increased risk of coronary artery disease (CAD) in patients with hypertension and the fact that this risk if not reduced with antihypertensive treatment are due to the clustering of risk factors for CAD, in addition to high blood pressure, associated with insulin resistance. These include hyperinsulinemia, IGT, increased plasma triglyceride concentration, and decreased high-density lipoprotein cholesterol concentration, all of which are associated with increased risk for CAD. It is likely that the same risk factors play a significant role in the genesis of CAD in the population as a whole. Based on these considerations the possibility is raised that resistance to insulin-stimulated glucose uptake and hyperinsulinemia are involved in the etiology and clinical course of three major related diseases— NIDDM, hypertension, and CAD.

Study of serum insulin levels in patients of euglycemic essential hypertension: a cross sectional study in North Indian population

Blood Pressure Trends, Plasma Insulin Levels and Risk Factors in Rural and Urban Elderly Populations of North India.

Clinical Study of the Relationship Between Essential Hypertension and Metabolisms of Glucose and Lipids

A study of sympathetic activity in hypertensive patients with hyperinsulinemia

Serum Ferritin in Metabolic Syndrome-Mechanisms and Clinical Applications

A Study on Serum Nitric Oxide and Hydrogen Sulfide in Essential Hypertension Cases in a Tertiary Care Hospital in West Bengal

Interrelations of Serum Uric Acid, Beta-Cell Function, and Insulin Resistance in Indian Cohort: A Comprehensive Analysis

A study on insulin resistance, endothelin and atrial natriuretic factor in patients with essential hypertension complicated by hyperlipidemia

Serum Calcium Levels in Patients with Essential Hypertension: A Cross-Sectional Study in a Tertiary Hospital of Bangladesh

Correlation Between Blood Pressure and Insulin Resistance and Secretion in Population with Normal Glucose Tolerance.

A STUDY OF SERUM URIC ACID LEVELS IN TYPE 2 DIABETES MELLITUS CASES AND ITS COMPARISON WITH THE SERUM CREATININE LEVELS

Hyperinsulinemia Rather Than Insulin Resistance Itself Induces Blood Pressure Elevation In High Fat Diet-Fed Rats

HYPERTENSION CONTROL, STILL A CAUSE OF CONCERN IN THE ELDERLY POPULATION WITH DIABETES & DYSLIPIDEMIA — A MULTICENTRE STUDY ACROSS INDIA

Association of Fasting Serum Insulin,Proinsulin and Leptin Levels with Hypertension in Over-weight or Obese Subjects

Type-2 diabetes mellitus with or without metabolic syndrome and their associated critical factors: A study from Northern India

The Clinical Implications of Fasting Serum Insulin Levels in Patients with Insulin-Treated Type 2 Diabetes: a Cross-Sectional Survey

Correlation of serum Nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome

A Study of Lipid Profile and the Correlation of Serum Uric Acid Levels in Patients With Hypertension

Role of Insulin Resistance in Human Disease

Exploring the link between leptin levels and metabolic syndrome in elderly Indian patients: Implications for family medicine and primary care practices

Blood Glucose Profile of Patients with Essential Hypertension in China